Stratified medicine in practice : review of predictive biomarkers in European Medicines Agency (EMA) indications

Keyphrases

• Practice Review 100%
• European Medicines Agency 100%
• Stratified Medicine 100%
• Predictive Biomarker 100%
• Subgroup Analysis 20%
• Strength of Evidence 20%
• Enrichment Design 20%
• Strategy Design 20%
• Mental Health 10%
• Clinical Practice 10%
• Lung Cancer 10%
• Colorectal Cancer 10%
• Adverse Events 10%
• Breast Cancer 10%
• Gastric Cancer 10%
• HIV Infection 10%
• Trial Design 10%
• Patient Benefit 10%
• Methodological Limitations 10%
• Differential Response 10%
• Design Study 10%
• Marker-based 10%
• Marketing Authorization 10%
• Indications for Treatment 10%
• Orphan Designation 10%
• Therapeutic Indications 10%
• Hematological Diseases 10%
• Treatment of HIV Infection 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Human Immunodeficiency Virus Infection 12%
• Colorectal Carcinoma 6%
• Lung Cancer 6%
• Malignant Neoplasm 6%
• Adverse Event 6%
• Breast Cancer 6%
• Abdominal Cancer 6%
• Hematologic Disease 6%

Biochemistry, Genetics and Molecular Biology

• Human Immunodeficiency Virus 100%
• Mental Health 50%